MINIMAL RESIDUAL DISEASE (MRD) ANALYSIS FOR B- ALL

Detection of Minimal Residual Disease (MRD) in Acute lymphoblastic leukemia predicts outcome. This assay can identify patients at higher/lower risk of relapse. Detection of MRD is important for risk assessment and stratification of therapy.

  • Test Type:
  • Pre-test Information:
    Following requirements are mandatory: • Date & Time of sampling • Previous immunophenotype report • Clinical history
  • Report Delivery:
    Sample Daily by 9 am; Report Next day
  • Components:
    0

Sample Report